SO-32 Predictive impact of RNF43 mutation (mut) in pMMR/MSS BRAFV600E-mutated metastatic colorectal cancer (mCRC) patients (pts) treated with target therapy (TT) or chemotherapy (CT)
Autor: | Germani, M., Moretto, R., Ros, J., Intini, R., Ghelardi, F., Vetere, G., Toledo, R., Bergamo, F., Randon, G., Elez, E., Lonardi, S., Oldani, S., Giordano, M., Rossini, D., Bravo, W. Ferrari, Ricagno, G., Vignali, P., Ugolini, C., Fontanini, G., Cremolini, C. |
---|---|
Zdroj: | In Annals of Oncology June 2023 34 Supplement 1:S176-S176 |
Databáze: | ScienceDirect |
Externí odkaz: |